Literature DB >> 21034709

[Plaque-phase mycosis fungoides treated with photodynamic therapy: results from 12 patients].

M Fernández-Guarino1, A Harto, B Pérez-García, C Montull, E De Las Heras, P Jaén.   

Abstract

BACKGROUND: Recent years have seen an increase in the off-label use of photodynamic therapy for the treatment of a variety of skin diseases. Plaque-phase mycosis fungoides is among the most promising possibilities for the use of this treatment.
OBJECTIVES: To evaluate the treatment of plaque-phase mycosis fungoides with photodynamic therapy and compare the results obtained using fluorescence photography.
MATERIALS AND METHODS: We performed a prospective, descriptive, observational study. Twelve patients with 24 lesions were treated with topical methyl aminolevulinate (MAL) under an occlusive dressing for 3 h, followed by 8 min of red light (630 nm, 37 J/cm2; Aktilite).
RESULTS: Six patients had a complete response, 5 a partial response, and 1 did not respond to treatment. A mean of 5.7 sessions was applied and no side effects were reported. Treatment tolerance was excellent.
CONCLUSIONS: Photodynamic therapy with MAL appears to be a good treatment option for patients with plaque-phase mycosis fungoides with a small number of lesions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034709

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  3 in total

1.  Epigenetically Enhanced PDT Induces Significantly Higher Levels of Multiple Extrinsic Pathway Apoptotic Factors than Standard PDT, Resulting in Greater Extrinsic and Overall Apoptosis of Cutaneous T-cell Lymphoma.

Authors:  Katrin A Salva; Youn H Kim; Ziba Rahbar; Gary S Wood
Journal:  Photochem Photobiol       Date:  2018-05-20       Impact factor: 3.421

2.  Epigenetically Enhanced Photodynamic Therapy (ePDT) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T-Cell Lymphoma.

Authors:  Katrin Agnes Salva; Gary S Wood
Journal:  Photochem Photobiol       Date:  2015-10-12       Impact factor: 3.421

3.  Emerging treatment options for early mycosis fungoides.

Authors:  Montserrat Fernandez-Guarino
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.